Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details)

v3.21.2
Stockholders’ Equity (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 14, 2021
Aug. 10, 2021
Jul. 14, 2021
Jan. 06, 2021
Sep. 17, 2021
Jun. 01, 2021
Feb. 28, 2021
May 31, 2020
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Jul. 31, 2021
Stockholders’ Equity (Textual)                            
Common stock per share (in Dollars per share)                 $ 0.001   $ 0.001   $ 0.001  
Convertible Preferred Stock Shares Issued (in Shares)                           65,953
(in Shares)                           25,062
Warrants to purchase common stock, description       On January 6, 2021, The Company issued 72,369 shares of common stock and 90,461 5 year warrants to purchase shares of common stock at $4.00 per share pursuant to the prior receipt of $275,000 in equity financing.                     
Common shares issued (in Shares)         298,883       11,060,656   11,060,656   9,895,600  
Common stock placement (in Shares)         298,883                  
Warrant additional         5 years                  
Warrant to purchase price         $ 1.79                  
Aggregate gross proceeds         $ 525,000                  
Common stock shares issued $ 27,403 $ 5,458 $ 29,025     $ 96,757     $ 191,078 $ 847,200 $ 323,635 $ 2,605,390    
Accounts payable           $ 132,557                
Fair value price per share (in Dollars per share) $ 2.26 $ 2.55 $ 2.95     $ 1.37                
Accounts payable $ 61,930 $ 13,919 $ 85,622                      
Common stock shares issued   11,611                        
Accounts payable   $ 29,607                        
Fair value price per share (in Dollars per share)   $ 2.55                        
Stockholders’ equity description               the Company received $515,000 of a committed $565,000 from the sale of 135,527 shares of common stock (at a price of $3.80 per share) and warrants to purchase 169,409 shares of common stock, at an exercise price of $4.00 per share. As of September 30, 2021, the full amount has not been received and only $415,000 worth of the shares and warrants have been issued. The remaining $125,000 is included in equity financing within current liabilities on the consolidated balance sheet.            
Unrecognized expense                     $ 1,700,000   $ 2,500,000  
Vested Restricted Stock Units [Member]                            
Stockholders’ Equity (Textual)                            
Stock conversion, description                     Between January 25, 2021 and August 13, 2021, the company issued a total of 504,965 shares of common stock to holders of fully vested restricted stock units.       
Maximum [Member]                            
Stockholders’ Equity (Textual)                            
Unrecognized expenses to be recognized, term                     4 years      
Minimum [Member]                            
Stockholders’ Equity (Textual)                            
Unrecognized expenses to be recognized, term                         3 years  
Common Stock [Member]                            
Stockholders’ Equity (Textual)                            
Common stock, shares authorized (in Shares)                 45,000,000   45,000,000      
Common stock shares issued                 $ 73 $ 157 $ 170 $ 442    
Series A Convertible Preferred Stock [Member]                            
Stockholders’ Equity (Textual)                            
Preferred stock, shares authorized (in Shares)                 900,000   900,000      
Stock conversion, description             During February 2021, the Company issued 52,632 shares of common stock to a holder of its Series A Convertible Preferred Stock upon the conversion of 20,000 of such shares of Series A Convertible Preferred Stock.